Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Safety Meetings: Outpatient Drugs, Hypoglycemia Getting Limelight

Apr 24 2017

• By Michael Cipriano

Clouds-Lightning-Storm_1200x675

Related Content

CDER’s Counter-Terrorism, Emergency Coordination Operations Get New Home

Sep 04 2014

US FDA Strategy On Abuse-Deterrent Opioids Needs Rethinking, Panelists Say

Mar 15 2017

FDA Launches Safe Use Initiative; Details To Evolve Through Stakeholder Input

Nov 05 2009

Opioid Policy At US FDA: Gottlieb Seeks More Activist Role To Combat Abuse

Apr 07 2017

Clinical Reviewers To CDER: Give Us PRO Training

Apr 13 2015

Quality-Of-Life, Emotional Well-Being Becoming Highly Utilized PROs In Diabetes Trials

Dec 06 2016

FDA Patient Affairs Office Needed To Improve Conflict Of Interest, NORD Says

Oct 26 2015

Diabetes Trials Could Include Hypoglycemia As Patient-Reported Outcome

Aug 31 2016

CDER Outreach Coordinator’s First Task Is Safe Use Initiative

Nov 07 2013

Additional Topics

United States Drug Safety Risk Management FDA Regulation Diabetic Care BioPharmaceutical

More from Drug Safety

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window